Junta de Castilla yLeón announced this Wednesday “Prophylactic” suspension of AstraZeneca vaccination for people under 65 After waiting for the European Medicines Agency (EMA) to make a ruling on its safety, some European countries have reported cases of thrombosis.
In this sense, EMA has convened A press conference will be held this Wednesday at 4:00 pm The vaccine and its relationship with coagulation events are reviewed.
EMA is a decentralized agency of the European Union, which conducts its work “independently, openly and transparently” to ensure “Scientifically evaluate, supervise and monitor drug safety For human and veterinary use in the European Union”, Stand out on the official website.
In this way, the agency is responsible for evaluating and verifying the safety of any vaccine for subsequent authorization and management in the general population. EMA was founded in 1995 and is headquartered in Amsterdam (Netherlands), To protect and promote human and animal health, and to work directly with the national regulatory agencies of member states and with counterpart agencies such as the European Center for Disease Prevention and Control (ECDC).
The goal of the agency Authorization and detailed monitoring Among all the medicines sold by the alliance. Therefore, for pharmaceutical companies to be able to sell their products, they must first request a review and subsequent authorization, which is finally issued by the European Commission.
this road, The main tasks of EMA are as follows: